Viewing Study NCT00809250

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:04 PM
Ignite Modification Date: 2026-02-03 @ 10:32 AM
Study NCT ID: NCT00809250
Status: COMPLETED
Last Update Posted: 2020-09-16
First Post: 2008-12-15
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation
Sponsor: Dana-Farber Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Chronic Myelomonocytic Leukemia View
None Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts View
Keywords:

Keywords

Keyword Brief Keyword Text View
None vaccination View
None AML View
None CMML View
None MDS-RAEB View